About Placebo Center Team

Dr. Cuneyt Tegin is a board-certified psychiatrist and addiction medicine specialist with a deep interest in the mind-body connection, meaning-centered healing, and the clinical application of placebo science. Dr. Tegin leads interdisciplinary efforts to understand how expectation, context, and therapeutic relationships shape medical outcomes, especially in mental health care.

With extensive clinical experience and a background in both evidence-based medicine and integrative approaches, Dr. Tegin’s work explores the ethical use of placebo mechanisms to enhance healing without deception. His research focuses on placebo interventions, the role of belief and meaning in psychiatric treatment, and how clinical environments can be optimized for trust, engagement, and patient empowerment.

Based in California, Dr. Tegin also leads outpatient psychiatric programs and digital mental health initiatives, where insights from placebo research are translated into practical strategies for care delivery, technology design, and provider-patient communication.

He believes that understanding the placebo effect is essential to understanding the human dimensions of healing, and that doing so can help bridge the science of medicine with the art of compassionate care.

Dr. Nalan Varsak is a psychiatrist with a clinical background and a growing interest in the mechanisms that influence treatment outcomes, including the placebo effect. She earned her medical degree in Turkey and completed her residency in psychiatry, where she worked with patients facing complex psychiatric conditions in both inpatient and outpatient settings. Her career has included service in public hospitals under resource-limited conditions, where she often had to rely on clinical insight and therapeutic alliances to support patients with limited access to formal therapies.

Dr. Varsak has broadened her clinical and academic perspective through international observerships, including at Massachusetts General Hospital in Boston and Metropolitan State Hospital in Los Angeles. These experiences deepened her curiosity about how expectations and context influence outcomes across cultures and health systems. Her interest in the placebo effect began during her clinical years, as she observed how patients’ expectations, trust in their physicians, and the therapeutic setting significantly influenced their responses to treatment, even in the absence of pharmacological change.

As a contributor to this project, Dr. Varsak is currently focused on identifying and analyzing studies that explore the role of placebo in psychiatry and other fields, aiming to highlight its overlooked role in healing.

Eda Nur Demirag, MD is a medical doctor with a dedicated focus on psychiatry and the neurocognitive mechanisms that shape mind-body interactions. She obtained her medical degree from Georgian National University SEU in 2024. During her clinical training, she completed an internship at Izmir Tınaztepe University Hospital and actively participated in several academic symposia, including an advanced workshop on Emotion Regulation.

Currently preparing for the USMLE, Dr. Demirag plans to pursue residency training in psychiatry in the United States. As a researcher at the Placebo Center, she is particularly interested in the placebo effect, not merely as a control condition, but as a powerful psychobiological phenomenon that reflects the brain’s capacity to influence perception, emotion, and symptom modulation. Her work explores how therapeutic expectation, belief, and context may be ethically and scientifically integrated into psychiatric treatment models to enhance clinical outcomes.